B-hBCMA/hGPRC5D MC38_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen,drug development,antibody discovery

Please input keywords

Order

*Country

日本

アメリカ

中国

オーストラリア

シンガポール

イギリス

フランス

ドイツ

スイス

イタリア

カナダ

韓国

オランダ

ベルギー

スウェーデン

その他

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

B-hBCMA/hGPRC5D MC38

Common name	B-hBCMA/hGPRC5D MC38	Catalog number	322252
Aliases	BCM, BCMA, CD269, TNFRSF13A; /	Disease	Colon carcinoma
Organism	Mouse	Strain	C57BL/6
Tissue types	Colon	Tissue	Colon

Protein expression analysis

from clipboard

BCMA and GPRC5D expression analysis in B-hBCMA/hGPRC5D MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hBCMA/hGPRC5D MC38 cultures were stained with species-specific anti-BCMA antibody (in house) and anti-GPRC5D antibody. Human BCMA and GPRC5D were detected on the surface of B-hBCMA/hGPRC5D MC38 cells. The 3-D03 clone of B-hBCMA/hGPRC5D MC38 cells was used for in vivo tumor growth assays.

Tumor growth curve & body weight changes

from clipboard

Subcutaneous homograft tumor growth of B-hBCMA/hGPRC5D MC38 cells. B-hBCMA/hGPRC5D MC38 cells (5x10⁵; 1x10⁶; 5x10⁶) and wild-type MC38 cells (5x10⁵) were subcutaneously implanted into C57BL/6 mice (female, 8-10-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm³ using the formula: V=0.5 X long diameter X short diameter². As shown in panel A, B-hBCMA/hGPRC5D MC38 cells were able to form tumors in vivo and can be used for efficacy studies.